Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag

Ítems similars

• Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects
  per: Kaufmann, Priska, et al.
  Publicat: (2015)
• Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment
  per: Kaufmann, Priska, et al.
  Publicat: (2016)
• A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist
  per: Hoch, Matthias, et al.
  Publicat: (2014)
• Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects
  per: Bruderer, Shirin, et al.
  Publicat: (2017)
• First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension
  per: Geerdink, Lianne M., et al.
  Publicat: (2017)